Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

RecruitingOBSERVATIONAL
Enrollment

486

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Graves DiseaseAmiodarone-Induced ThyrotoxicosisThyroidectomy
Trial Locations (15)

8400

RECRUITING

Kantonsspital Winterthur, Zurich

Unknown

RECRUITING

OLV Ziekenhuis, Aalst

RECRUITING

Universite de Lorraine, Cru Nancy, Nancy

RECRUITING

Evgenidion Hospital Athens, Athens

RECRUITING

Universitario Virgen de las Nieves, Granada

RECRUITING

Hospital Costa del Sol, Marbella

NOT_YET_RECRUITING

Clarunis St. Clara Spital, Basel

RECRUITING

Universitätsspital Bern, Inselspital, Bern

RECRUITING

University Hospitals of Geneva, Geneva

RECRUITING

University Hospital of Lausanne CHUV, Lausanne

NOT_YET_RECRUITING

Kantonsspital Basel Land, Liestal

RECRUITING

Spital Männedorf, Männedorf

RECRUITING

Ospedale Regionale di Mendrisio, Mendrisio

RECRUITING

HOCH Kantonsspital St. Gallen, Sankt Gallen

RECRUITING

Spital Limmattal, Schlieren

All Listed Sponsors
collaborator

Spital Männedorf

UNKNOWN

collaborator

Spital Limmattal Schlieren

OTHER

collaborator

Centre Hospitalier Universitaire Vaudois

OTHER

collaborator

Ospedale Regionale di Mendrisio

OTHER

collaborator

Kantonsspital St. Gallen, Switzerland

UNKNOWN

collaborator

Cantonal Hosptal, Baselland

OTHER

collaborator

St. Claraspital AG

OTHER

collaborator

University Hospital, Geneva

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

ASZ Aalst

OTHER

collaborator

University Hospital Virgen de las Nieves

OTHER

collaborator

University of Nancy

OTHER

collaborator

Hospital Costa del Sol

OTHER

collaborator

Evgenidion Hospital Athens, Greece

UNKNOWN

lead

Andrea Goldmann

OTHER

NCT06963203 - Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis | Biotech Hunter | Biotech Hunter